Share on Pinterest Adding blood thinners to clot-busting medication after a stroke does not appear to improve the outcomes, according to a new study. credit: szjphoto/Getty Images. About 15 million ...
An investigational anti-clotting medication, asundexian, has demonstrated a reduction in the risk of a second ischemic (clot-caused) stroke without raising bleeding concerns, according to a ...
Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and adults are among the major updates in the new 2026 Guideline for the Early ...
Global phase 3 OCEANIC-STROKE randomized 12,327 patients to asundexian 50 mg daily vs placebo on background antiplatelets, with follow-up to 31 months. Treatment effects were consistent across TOAST ...
Stroke is a leading cause of death and disability worldwide, with staggering statistics that demand urgent attention. Every year, approximately 12.2 million new strokes are diagnosed globally, and one ...
New research uncovers how cultural, social, and healthcare challenges impact medication adherence among women, offering insights to reduce stroke recurrence disparities. Study: Sex Differences in ...
The Hearty Soul on MSN
A nasal spray that could protect your brain during a stroke
A Hong Kong team's NanoPowder nasal spray stroke treatment reduced brain damage by 80% in animal studies. Here's what the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results